About Bushu Pharmaceuticals
Bushu Pharmaceuticals is a company based in Kawagoe (Japan) founded in 1998 was acquired by BPEA EQT in November 2014. Bushu Pharmaceuticals operates in a competitive market with competitors including Akums, Jubilant Life Sciences, Unither, Recipharm and Nectar Lifesciences, among others.
- Headquarter Kawagoe, Japan
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Bushu Pharmaceuticals
Detailed funding history for Bushu Pharmaceuticals
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Bushu Pharmaceuticals
Bushu Pharmaceuticals has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include BPEA EQT and T Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity and real estate investment firm
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Bushu Pharmaceuticals
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Bushu Pharmaceuticals
Investment portfolio details for Bushu Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Bushu Pharmaceuticals
Detailed financials for Bushu Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bushu Pharmaceuticals Comparisons
Peer comparison for Bushu Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Bushu Pharmaceuticals
Bushu Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Akums, Jubilant Life Sciences, Unither, Recipharm and Nectar Lifesciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
CDMO focusing on spectrum of dosage forms and therapeutic segments
|
|
| Locked | Locked | Locked |
Company offering a suite of R&D and manufacturing services for small molecules and generics
|
|
| Locked | Locked | Locked |
Contract development and manufacturing organization for proprietary and generic drugs
|
|
| Locked | Locked | Locked |
Pharmaceutical development and manufacturing services are offered contractually.
|
|
| Locked | Locked | Locked |
Cephalosporin APIs and generic formulations are manufactured.
|
|
| Locked | Locked | Locked |
Biopharma regulatory affairs, quality control, and strategy services are provided.
|
Detailed competitors of Bushu Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bushu Pharmaceuticals
Complete news archive for Bushu Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bushu Pharmaceuticals
Bushu Pharmaceuticals was founded in 1998.
Bushu Pharmaceuticals is headquartered in Kawagoe, Japan. It is registered at Kawagoe, Saitama, Japan.
Bushu Pharmaceuticals was established in 1998 in Kawagoe, Japan, where operations as a contract manufacturing organization in the pharmaceutical sector are conducted. Two manufacturing facilities and a pharmaceutical laboratory are maintained. Formulation and dosage design for hormones, high-potency drugs, and biopharmaceuticals in solid forms are provided, along with packaging and injectables for clinical samples. Acquisition by Baring Asia from Tokyo Marine Capital occurred in November 2014 for 670 million.
Bushu Pharmaceuticals's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Bushu Pharmaceuticals has 2 investors. Key investors include BPEA EQT, and T Capital Partners.